{"name":"BioRestorative Therapies","slug":"biorestorative-therapies","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BRTX-100","genericName":"BRTX-100","slug":"brtx-100","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BRTX-100","genericName":"BRTX-100","slug":"brtx-100","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNT1d1VDVrVUFBUXVnS1RBSjRfZnB2OUxXMnJneC11XzlhV3g5WkE5UUUzUVlnYVFJQ05VdXpEdU9oWkJzNU1CTnlJa2N2dnNDRkw4UkxFam9TZWgwem5YSkdQNXBsMUszYjZCZTZjSjJMZGYyZkN1RUM2RENQbUdadldLWEZiZnFLYTd2NG1XR2V1NXBkNWtKUDFGWGJsTnNSUDNrSExzbWF3Z2dTT1VyUDRmOWRDRFl2cWxjZDh6UGJzZGVUMHI4RmJpM1dackhFVkJ3VFppNkFjT3VLNUwtZ1pjMXFDVGRmZzQzYkdXdl83SjlhTnVsM0x0cjMtdE04VXJBNVdxc09aSXZNWk02OGdidGp5SGE5VjdZNWVmRXFLdXJzN0hmY1Y0VnZPemVnOXVrZHRpbmFpNW5SR2JlT3ZMQ1hfcWNDcU9z?oc=5","date":"2026-04-03","type":"regulatory","source":"Barchart.com","summary":"Obesity Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Merck, Alizyme, Bayer, GlaxoSmithKline, Bristol-Myers Squibb, Currax Pharma, Roche - Ba","headline":"Obesity Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Merck, ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPSGtiX2hPZWszV2stV2RIck1ELVM5QXNKOVFuSURndTNGX2c4UXBiYTRLUkJGcGM1RmNKS3p0YV9aUVJoSTVYcFlBa2ZMbVZVMHR4cFRGX0xESEQ3dUZlRHAxdnNMa2RXUHR0QmVlQmRLWHJPbG5NQ0twejlkT1BvV2VDaDZRU3RlZVRuS0hGMGVTSFNRaE5hbHE1cDVIZVph?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum - openPR.com","headline":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5LMDNYZ3dib1JUYVVKOVkwemRMaEpfTjg3QThGenhkWHJMOThyb2xfaFpOR3hVMVd6N0JwYWNHZFdKSnh3NFE4WGd6dmNpTWZfbUVUWGRlT2tZcklyOUHSAWNBVV95cUxNc2xoR1VXS0xxWU45WWJGU1M2RjVTZndNcFhzZmdGWkdlRnhqb005XzhJY2FiUm5aSDBRYXR6QWJYbEVYWFltNzE3cUd3UVd4MHdXTExtRHNYMDhQUENRNkNXdXM?oc=5","date":"2026-03-19","type":"earnings","source":"Bitget","summary":"Eton Pharmaceuticals, Inc. (ETON) Q4 Results Fall Short of Projections - Bitget","headline":"Eton Pharmaceuticals, Inc. (ETON) Q4 Results Fall Short of Projections","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOVUZSX3JMMEhNaEtsck1SZEpJaDRNNEpLN1k5M00yNHY0b2tHMnBEcC1TNVk1enYxRHFuMWJlZUh4MjJEdG0zNnluYXpCNU9NYkVsa01CRXAwV05zcWNwMTg3anpwWVRjNEFsU09vMnYwNXptQ0gyOVcwWUNLTXhfV2hQck9ueXdGcnMtbGVrNDIxT2VETjBBRW9BVWpOUzBhQ0ZfcDdzSkVXSGs1dTV6ekxjQQ?oc=5","date":"2026-02-10","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's Intraday Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-05","type":"earnings","source":"simplywall.st","summary":"BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook - simplywall.st","headline":"BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNZjVyUVRCNTZDcUxOYlNzd1dRSWZrUE1Qdlh1cEVNY2VHT0c0YU93U1ZuVnpCbzBlMDBkcUxGeHlFbktQbmhaQmpLOGF4bm92cDUxbHpTLUtlbzJ2amVnVy1ieXlsWElUcDRWQ0pYc1Q1N2c1R3hzS1lGcTM4R3dIV1hyTS1Ma0JCRlc5MGduX3V0REYxOVN3QmUwSVFReUVVX3VaUUV3SUJsTGlZTzYtZmFua0NIUnprUmp1V1N0amtUOHNzMTZPbEdQQkhpZ3NnYVI3cENlY25CcXktR3dmaFR0aGIzUExRaE95WmYwRzk1b0kzenNaLWVRMVk5Zw?oc=5","date":"2025-02-27","type":"pipeline","source":"GlobeNewswire","summary":"WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight - GlobeNewswire","headline":"WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOZF9HR0cwWTltNmtaWGNhQ0JxbUxDaF8tdWhIZHRYRUg2NkpzUUFReU5MSGRTcy05QU55cFpYZ1VPLS1YV2hWeUdQOXl5dlRwbDNUek5iOUVGU01KSVMyd3k3dkFjeDdDQXgtTDRidlFuNW5UcHJXNHlRRTZSZm1zX0lsYzBfTmJPaWFuUUowaWJIbWxWZE1idHBWak9leWpBLTFzNUdLX18wcjkyaFlfT2JIbkFZTGViTndzSHJZQ3pWX01xeTRCV1hhRTlOQXNwZVVIM1llS1dsLWJwTXRpLW9sbW5MWUV3SmRxR1VESVJ4amJ3THRnTm9OcHdsV1ZsTHlzYjhOU2dCZGpDUkNQT3o2X0d2My1QakpfVTN0X3c4elN1a2FtdnN0ZXk4dw?oc=5","date":"2024-08-06","type":"trial","source":"GlobeNewswire","summary":"Obesity Clinical Trial Pipeline Appears Robust With 80+ Key - GlobeNewswire","headline":"Obesity Clinical Trial Pipeline Appears Robust With 80+ Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPTm1iOVZkUkcwdDV3cF90OEpGZ3VLbGdJQ0ZaWDNFa3BlMUF0ZS1CUTB5TWV2eHlFbkh1cXl6RjJFaHZlR1RVLVNTd1FDM19RRExiaEJIYndWWEk5ekp5aUlXNXRNbXFIYkFFUDlhOGdSRlRNZDlSN2IwekIyZ0ZES1FfdTVFY0JacTY3Z3Q3WE9kbUtERl9kVlFIY3Yzd2pqN19Wc1VHeHhNNU9ZZF9wa29qeDNDZC1wVFRFOGVSQTlRdTNNem5XRnJWR1lLNkRJOXBIZ2lSd0E0WU44dXhaaVo1dlkwdjR2Q3F6bUZkM3JkamtCTVYyMEhDQVRZLXBqd0VHWGctQmtLb2tyaC1mSk9RcEZVZ2RtUzdQZDRVcW9oLUV1VHMwbnVvczVlUUFTX3dz?oc=5","date":"2024-07-23","type":"trial","source":"GlobeNewswire","summary":"GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ - GlobeNewswire","headline":"GLP Agonist Clinical Trial Pipeline Appears Robust With 20+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNZXkyTGtGaDllNVk2OURmdDItTVg4Q2U1dTRqVjZ0X1J2UzdIT2pZUlp0ZmtaalJsVS1tUWswMVhvYTZHcTRxZDhjRFV1b2VjU21lMV9iSWxYTkFmTlNKNWJhc0F3SzJ3NGw3cHFnRE8yU3JuSXhjYWp5Ui0xQU13QjlNRFR1VVgyT09xaHRKRVlnbHBTckQtbVlUdjB4eTVnaGczcTRUWmJTd0xDdkl5YlUwcG42azQzbFhZSk9LQkwtSU1sTUNzYjQ0RU5QX2p2Q3hQYjNLY2haVWZjTjkzczNUQjBhTFJpb1h3dGFJaGZVOG1fNzVDUg?oc=5","date":"2024-07-17","type":"pipeline","source":"GlobeNewswire","summary":"Global Peptide Therapeutics Market to Grow Significantly at a CAGR of ~10% by 2030| DelveInsight - GlobeNewswire","headline":"Global Peptide Therapeutics Market to Grow Significantly at a CAGR of ~10% by 2030| DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPaV9rX1ZHUzN5Y3ZPZG1QMXl6ejYyQV81S04zMlZGV2FaSkQydEdVU1lfWG5Cbk5VcGxLZUhQZS1PbHd2Qmh1c3pQSUtaYzNDb19oQXVvVzM2ZWNUMG1uUjBYOXl5NGlJTWpFbTdrRURRaUMzWGYyWEJQT2dJN0VFWVc0TWpFbTZJWVBieHo3X2pGaFJRWnVJ?oc=5","date":"2022-12-20","type":"pipeline","source":"openPR.com","summary":"Obesity Pipeline Drugs and Companies Insight Report (2022): - openPR.com","headline":"Obesity Pipeline Drugs and Companies Insight Report (2022):","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}